Similarly, Insulin-like growth factor-2 mRNA-binding proteins (IGF2BP1/2/3) have been found to be overexpressed in AML, and to regulate the stability of specific mRNAs, including MYC, in an m6A-dependent manner to promote tumor progression [52–54]. The gene discussed is IGF2BP1; the disease is acute myeloid leukemia.